Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
GemPharmatech Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
GemPharmatech has a total shareholder equity of CN¥2.1B and total debt of CN¥108.1M, which brings its debt-to-equity ratio to 5.1%. Its total assets and total liabilities are CN¥2.6B and CN¥501.0M respectively. GemPharmatech's EBIT is CN¥95.5M making its interest coverage ratio -3.9. It has cash and short-term investments of CN¥1.3B.
Anahtar bilgiler
5.1%
Borç/özkaynak oranı
CN¥108.11m
Borç
| Faiz karşılama oranı | -3.9x |
| Nakit | CN¥1.30b |
| Eşitlik | CN¥2.11b |
| Toplam yükümlülükler | CN¥500.99m |
| Toplam varlıklar | CN¥2.61b |
Son finansal sağlık güncellemeleri
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 688046's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥426.6M).
Uzun Vadeli Yükümlülükler: 688046's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥74.3M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 688046 has more cash than its total debt.
Borcun Azaltılması: 688046's debt to equity ratio has reduced from 5.1% to 5.1% over the past 5 years.
Borç Kapsamı: 688046's debt is well covered by operating cash flow (43.3%).
Faiz Kapsamı: 688046 earns more interest than it pays, so coverage of interest payments is not a concern.